IRWD · Ironwood Pharmaceuticals Inc · Executive Compensation
$4.67
-0.12 (-2.41%)
At close · Nov 19
Return incl. dividend (before tax)
Play latest call
Q3 2026 earnings call transcript
Market Cap
$767.33M
Shares
165.55M
Volume · Nov 19
948.72K
Avg daily vol (3M)
2.1M
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
No Compensation Data
No Summary Compensation Table has been imported from this company's proxy statements yet.
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| Thomas McCourt | Chief Executive Officer | Retired | 2026-10-16 |
| Tammi Gaskins | director | Appointed | 2026-10-16 |
| Tammi Gaskins | Chief Executive Officer | Appointed | 2026-10-16 |
| Ronald Silver | Senior Vice President, Corporate Controller and Chief Accounting Officer and interim chief financial officer and principal finan | Appointed | 2026-05-13 |
|
Gregory Martini
“Mr. Martini’s resignation is not due to any disagreement with the Company on any matter relating to the Company’s financial reporting.”
|
Senior Vice President, Chief Financial Officer | Resigned | 2026-05-13 |
|
Andrew Dreyfus
“Mr. Dreyfus’ decision to resign is due to his appointment as President and Chief Executive Officer of the National Institute for Health Care Management (NIHCM) Foundation and was not a result of any disagreement with the Company or any matter relating to the Company’s operations, policies or practices.”
|
Board of Directors | Resigned | 2025-10-10 |
| Gregory Martini | Senior Vice President, Chief Financial Officer | Appointed | 2025-01-29 |
| Thomas McCourt | principal financial officer on an interim basis | Appointed | 2024-12-05 |
|
Sravan K. Emany
“Mr. Emany’s resignation is not due to any disagreement with the Company on any matter relating to the Company’s financial reporting.”
|
Senior Vice President, Chief Operating Officer and Chief Financial Officer | Resigned | 2024-12-05 |
|
Sravan K. Emany
“Mr. Emany’s resignation is not due to any disagreement with the Company on any matter relating to the Company’s financial reporting.”
|
Senior Vice President, Chief Operating Officer and Chief Financial Officer | Resigned | 2024-12-05 |
| Andrew Davis | Senior Vice President, Chief Business Officer | Resigned | 2024-11-12 |
| Sravan K. Emany | Senior Vice President, Chief Operating Officer and Chief Financial Officer | Appointed | 2024-06-20 |
| Catherine Moukheibir | Director | Appointed | 2023-06-22 |
| Jay Shepard | Director | Appointed | 2023-06-22 |
| Julie McHugh | Director | Appointed | 2023-06-22 |
| Marla Kessler | Director | Appointed | 2023-06-22 |
| Thomas McCourt | Director |
Already on the board
Since at least 2021: re-election or new board role
|
2023-06-22 |
| Jon Duane | Director | Appointed | 2023-06-22 |
| Andrew Dreyfus | Director | Appointed | 2023-06-22 |
| Alexander Denner | Director | Appointed | 2023-06-22 |
| Mark Currie | Director | Appointed | 2023-06-22 |
|
Jason Rickard
“Mr. Rickard’s role elimination is not due to any disagreement with the Company on any matter relating to the Company’s operations, policies or practices.”
|
Senior Vice President, Chief Operating Officer | Terminated | 2023-04-11 |
| Sravan K. Emany | Senior Vice President, Chief Financial Officer | Appointed | 2021-12-01 |
Leadership
- Tammi Gaskins CEO, Board Member
- Julie McHugh Chairman, Board Member
- Gregory Martini CFO
- Jason Rickard CFO
- Ronald Silver CFO, Chief Accounting Officer
- Sravan K. Emany CFO, COO
- Thomas McCourt CFO, Board Member
- Gina Consylman Chief Accounting Officer
- Alexander Denner Board Member
- Alexander Denner, Ph.D. Board Member
- Andrew Dreyfus Board Member
- Catherine Moukheibir Board Member
- Jay P. Shepard Board Member
- Jay Shepard Board Member
- Jon Duane Board Member
- Mark Currie Board Member
- Marla Kessler Board Member
Key facts
CIK
1446847
CUSIP
46333X108
13F (30d)
243 filings
221 filers
Visit website
Investor relations